Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
June is Cancer Immunotherapy Month
Cancer-fighting T cells led to complete or partial tumor remission in at least 25% of lung cancer patients.
Edited T cells survive and thrive in three patients in the first U.S. trial using this approach.
Customized treatments demonstrate good response rates for mantle cell lymphoma and chronic lymphocytic leukemia.
Space travel and chemotherapy affect the body similarly, and yet only astronauts undergo physical conditioning to help them stay strong.
A look back at some of the major news stories we covered this year.
The new therapies include immune checkpoint inhibitors; therapeutic vaccines; CAR T-cell therapies; and “conjugate” drugs.
New tech enables deep dive into mysterious results, sets stage for future improvements.
New treatment approaches target tumors with shared characteristics, regardless of where they appear in the body.
Opdivo will be used to treat hepatocellular carcinoma, which can be caused by hepatitis B or C.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.